Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 6 | 2023 | 481 | 2.450 |
Why?
|
| Osteoporosis | 4 | 2022 | 77 | 2.390 |
Why?
|
| Familial Hypophosphatemic Rickets | 3 | 2023 | 4 | 2.330 |
Why?
|
| Bone Density | 14 | 2023 | 148 | 2.280 |
Why?
|
| Bone Matrix | 4 | 2017 | 30 | 2.030 |
Why?
|
| Bone and Bones | 9 | 2023 | 119 | 1.890 |
Why?
|
| Animals | 27 | 2023 | 3824 | 1.460 |
Why?
|
| Biomarkers | 8 | 2022 | 581 | 1.390 |
Why?
|
| X-Ray Microtomography | 10 | 2023 | 87 | 1.230 |
Why?
|
| Osteolysis | 5 | 2019 | 143 | 1.230 |
Why?
|
| Bone Remodeling | 4 | 2021 | 48 | 1.210 |
Why?
|
| Osteocalcin | 5 | 2022 | 25 | 1.190 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 13 | 1.190 |
Why?
|
| Parathyroid Hormone | 3 | 2021 | 24 | 1.150 |
Why?
|
| Glycoproteins | 3 | 2018 | 47 | 1.100 |
Why?
|
| Implants, Experimental | 3 | 2021 | 30 | 1.070 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 70 | 0.930 |
Why?
|
| Mice | 11 | 2023 | 1494 | 0.930 |
Why?
|
| Tooth | 1 | 2023 | 1 | 0.890 |
Why?
|
| Osseointegration | 3 | 2021 | 69 | 0.880 |
Why?
|
| Fractures, Bone | 2 | 2022 | 75 | 0.850 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2023 | 9 | 0.840 |
Why?
|
| Bone Development | 1 | 2023 | 34 | 0.820 |
Why?
|
| Joint Prosthesis | 2 | 2020 | 89 | 0.770 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 56 | 0.770 |
Why?
|
| Lactation | 2 | 2018 | 50 | 0.740 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 51 | 0.720 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 4 | 0.720 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 7 | 0.720 |
Why?
|
| Female | 16 | 2023 | 15534 | 0.700 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 336 | 0.650 |
Why?
|
| Bone Regeneration | 5 | 2021 | 77 | 0.630 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 6 | 0.630 |
Why?
|
| Weaning | 1 | 2018 | 5 | 0.630 |
Why?
|
| Minerals | 1 | 2018 | 5 | 0.630 |
Why?
|
| Male | 20 | 2023 | 15143 | 0.620 |
Why?
|
| Rats | 10 | 2021 | 675 | 0.600 |
Why?
|
| Titanium | 2 | 2021 | 183 | 0.590 |
Why?
|
| Osteogenesis | 4 | 2021 | 113 | 0.590 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 2 | 0.530 |
Why?
|
| Humans | 22 | 2023 | 28054 | 0.530 |
Why?
|
| Phosphates | 3 | 2021 | 20 | 0.520 |
Why?
|
| Mutation | 1 | 2016 | 358 | 0.460 |
Why?
|
| Antibodies | 1 | 2014 | 49 | 0.460 |
Why?
|
| Calcitonin | 1 | 2014 | 16 | 0.450 |
Why?
|
| Fracture Fixation | 1 | 2014 | 23 | 0.450 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 14 | 0.450 |
Why?
|
| Diphosphonates | 1 | 2014 | 16 | 0.450 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 12 | 0.450 |
Why?
|
| Absorptiometry, Photon | 3 | 2023 | 82 | 0.420 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 282 | 0.400 |
Why?
|
| Graft vs Host Disease | 2 | 2022 | 55 | 0.370 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 2 | 2021 | 3 | 0.360 |
Why?
|
| Fibroblast Growth Factors | 2 | 2021 | 6 | 0.360 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 2123 | 0.360 |
Why?
|
| Femur | 5 | 2021 | 392 | 0.350 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 115 | 0.350 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 815 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 66 | 0.340 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2023 | 20 | 0.330 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 33 | 0.330 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 233 | 0.320 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 1035 | 0.320 |
Why?
|
| Prosthesis Failure | 3 | 2020 | 538 | 0.310 |
Why?
|
| Polyethyleneimine | 3 | 2015 | 6 | 0.280 |
Why?
|
| Arthroplasty, Replacement | 2 | 2020 | 154 | 0.260 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 9 | 0.260 |
Why?
|
| Skull | 2 | 2015 | 23 | 0.240 |
Why?
|
| Calcium | 2 | 2018 | 377 | 0.240 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 28 | 0.230 |
Why?
|
| Periodontal Ligament | 1 | 2023 | 1 | 0.220 |
Why?
|
| Biomechanical Phenomena | 3 | 2020 | 670 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 10 | 0.210 |
Why?
|
| Osteocytes | 2 | 2019 | 18 | 0.210 |
Why?
|
| Anti-Retroviral Agents | 1 | 2022 | 19 | 0.200 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 163 | 0.200 |
Why?
|
| Hypogonadism | 1 | 2021 | 7 | 0.190 |
Why?
|
| Emtricitabine | 1 | 2021 | 2 | 0.190 |
Why?
|
| Infertility | 1 | 2021 | 8 | 0.190 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 19 | 0.190 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 928 | 0.190 |
Why?
|
| Femur Neck | 1 | 2021 | 19 | 0.190 |
Why?
|
| Rats, Zucker | 1 | 2021 | 7 | 0.190 |
Why?
|
| Ovariectomy | 1 | 2021 | 26 | 0.190 |
Why?
|
| Cartilage | 1 | 2022 | 104 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 633 | 0.190 |
Why?
|
| Collagen Type I | 1 | 2021 | 18 | 0.190 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 53 | 0.190 |
Why?
|
| Azepines | 1 | 2021 | 3 | 0.190 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2021 | 8 | 0.180 |
Why?
|
| Viral Load | 1 | 2021 | 74 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2021 | 21 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2021 | 33 | 0.180 |
Why?
|
| Triazoles | 1 | 2021 | 29 | 0.180 |
Why?
|
| Plasmids | 3 | 2015 | 45 | 0.180 |
Why?
|
| HIV-1 | 1 | 2023 | 235 | 0.180 |
Why?
|
| Adipose Tissue | 1 | 2021 | 78 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2021 | 175 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 492 | 0.170 |
Why?
|
| Body Weight | 1 | 2019 | 141 | 0.160 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 120 | 0.160 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2017 | 79 | 0.160 |
Why?
|
| Collagen | 2 | 2016 | 84 | 0.160 |
Why?
|
| Porosity | 1 | 2018 | 60 | 0.160 |
Why?
|
| Syndactyly | 1 | 2018 | 1 | 0.150 |
Why?
|
| Hyperostosis | 1 | 2018 | 1 | 0.150 |
Why?
|
| Anabolic Agents | 1 | 2018 | 4 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 1258 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 104 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 137 | 0.140 |
Why?
|
| Double-Blind Method | 1 | 2018 | 423 | 0.140 |
Why?
|
| Pregnancy | 1 | 2018 | 337 | 0.140 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 29 | 0.140 |
Why?
|
| Cortical Bone | 1 | 2017 | 7 | 0.140 |
Why?
|
| Prevalence | 1 | 2018 | 466 | 0.140 |
Why?
|
| Comorbidity | 1 | 2018 | 497 | 0.140 |
Why?
|
| X-Rays | 1 | 2016 | 6 | 0.130 |
Why?
|
| Middle Aged | 2 | 2021 | 9186 | 0.130 |
Why?
|
| Point Mutation | 1 | 2016 | 27 | 0.130 |
Why?
|
| Radiography | 1 | 2018 | 640 | 0.130 |
Why?
|
| Prognosis | 1 | 2018 | 818 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2018 | 664 | 0.130 |
Why?
|
| Independent Living | 1 | 2018 | 308 | 0.130 |
Why?
|
| RNA | 1 | 2015 | 36 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2016 | 266 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 47 | 0.120 |
Why?
|
| Phenotype | 1 | 2016 | 306 | 0.120 |
Why?
|
| Genotype | 1 | 2016 | 346 | 0.120 |
Why?
|
| Aged | 2 | 2018 | 9222 | 0.120 |
Why?
|
| Copper | 1 | 2014 | 14 | 0.120 |
Why?
|
| Chitosan | 1 | 2014 | 5 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 11 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 990 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 69 | 0.120 |
Why?
|
| Diaphyses | 1 | 2014 | 5 | 0.120 |
Why?
|
| Microvessels | 1 | 2014 | 14 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2015 | 325 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 449 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 47 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 25 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2014 | 43 | 0.120 |
Why?
|
| Fracture Healing | 1 | 2014 | 38 | 0.120 |
Why?
|
| Adult | 3 | 2022 | 8021 | 0.120 |
Why?
|
| Methamphetamine | 1 | 2014 | 22 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 79 | 0.120 |
Why?
|
| Joints | 1 | 2014 | 70 | 0.110 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 20 | 0.110 |
Why?
|
| Thiophenes | 1 | 2014 | 10 | 0.110 |
Why?
|
| Cognition | 1 | 2022 | 1352 | 0.110 |
Why?
|
| Corpus Striatum | 1 | 2014 | 66 | 0.110 |
Why?
|
| Models, Animal | 1 | 2014 | 121 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 78 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 6 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2014 | 85 | 0.110 |
Why?
|
| Humerus | 1 | 2014 | 120 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 306 | 0.110 |
Why?
|
| Tibia | 1 | 2014 | 257 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 715 | 0.100 |
Why?
|
| Bone Marrow | 2 | 2022 | 81 | 0.090 |
Why?
|
| Rats, Inbred F344 | 3 | 2015 | 35 | 0.090 |
Why?
|
| DNA | 3 | 2015 | 103 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4846 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 411 | 0.080 |
Why?
|
| Calcification, Physiologic | 2 | 2019 | 19 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 111 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2021 | 181 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 655 | 0.070 |
Why?
|
| Cell Survival | 2 | 2015 | 121 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2015 | 86 | 0.060 |
Why?
|
| Lamivudine | 1 | 2023 | 9 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 57 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 51 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2022 | 23 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2021 | 25 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 40 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2021 | 18 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 24 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 35 | 0.040 |
Why?
|
| Proteins | 1 | 2021 | 64 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 249 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 138 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1366 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 115 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 718 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 130 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 2 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 37 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 21 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 75 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3530 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2018 | 180 | 0.040 |
Why?
|
| Spine | 1 | 2018 | 110 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 329 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 19 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 7 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 52 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 32 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 5 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 16 | 0.030 |
Why?
|
| Self Administration | 1 | 2014 | 21 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 10 | 0.030 |
Why?
|
| Hypoxia | 1 | 2014 | 36 | 0.030 |
Why?
|
| Corrosion | 1 | 2014 | 134 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 167 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 80 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 123 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 93 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 60 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 432 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 206 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 501 | 0.030 |
Why?
|
| Risk Factors | 1 | 2014 | 2371 | 0.020 |
Why?
|